This article is 3 years old
MOH study confirms 'no benefit' in using ivermectin to treat Covid-19
A Health Ministry study has confirmed there is no benefit in repurposing the antiparasitic drug ivermectin to treat Covid-19, in line with high-quality studies published on the matter.
Instead, study participants who received ivermectin were three times more likely to report side effects compared to participants who didn’t – usually cases of diarrhoea...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable